Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers
J. E. Wiedmeier-Nutor et al · Nature Publishing Group · 2026
Accesso alla risorsa
Apri il contenuto dall’opzione principale o scegli un’altra fonte disponibile.
Accesso aperto disponibile
Come citare
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, J. E. W. N. E. (2026). Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers. https://doi.org/10.1038/s41408-026-01508-9
MLA
al, J. E. Wiedmeier-Nutor et. "Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers." 2026. https://doi.org/10.1038/s41408-026-01508-9.
Chicago
al, J. E. Wiedmeier-Nutor et. 2026. "Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers.". https://doi.org/10.1038/s41408-026-01508-9.
Harvard
al, J. E. W. N. E. 2026, Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers, Nature Publishing Group, available at: https://doi.org/10.1038/s41408-026-01508-9 [Accessed 10 Aug. 2026].
Dettagli della risorsa
Informazioni bibliografiche utili per verificare che sia il materiale corretto.
- Titolo
- Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers
- Autore / collaboratori
- J. E. Wiedmeier-Nutor et al
- Editore
- Nature Publishing Group
- Anno di pubblicazione
- 2026
- ISSN
- 2044-5385
- ISSN
- 2044-5385
- Lingua
- Inglés